BioCentury | Aug 25, 2020
Management Tracks

Former head of gRED Varney joining Erasca; plus AAM, City of Hope, Immunovant, Kura, Illumina and more

...Omead Ostadan, who left the tools company in June. Reeves joins from Cardinal Health Inc. (NYSE:CAH...
BioCentury | Feb 20, 2020
Finance

With $88M series B, Spruce seeks short path to approval in rare endocrine disorder

...which takes a non-steroidal approach to treating endocrine disorders such as classic congenital adrenal hyperplasia (CAH...
...IIb trials of tildacerfont (SPR001), its second-generation antagonist of CRFR1 to treat adults with classic CAH...
...disease that results in a lack of cortisol biosynthesis. There are no FDA-approved therapies for CAH...
BioCentury | May 21, 2019
Finance

Debt and equity investor K2HV seeks ‘profit and purpose’ in $400M launch

...Partner and K2HV co-founder and Chair Meghan FitzGerald was an executive at Cardinal Health Inc. (NYSE:CAH...
BioCentury | Dec 14, 2018
Company News

Millendo, OvaScience merge, raise $50M

...Pharma S.A.S. last year. Nevanimibe is in Phase IIb testing to treat congenital adrenal hyperplasia (CAH...
...Orphan Drug designation in the U.S. for CAH and CS, and in the EU for CAH...
BioCentury | Dec 7, 2018
Company News

Millendo, OvaScience merge, raise $50M

...Pharma S.A.S. last year. Nevanimibe is in Phase IIb testing to treat congenital adrenal hyperplasia (CAH...
...Orphan Drug designation in the U.S. for CAH and CS, and in the EU for CAH...
BioCentury | Jan 31, 2018
Company News

Amazon, Berkshire, JPM healthcare deal rocks incumbents

...value. The shares of the three major distributors -- AmerisourceBergen Corp. (NYSE:ABC), Cardinal Health Inc. (NYSE:CAH...
BioCentury | Nov 17, 2017
Company News

Cardinal Health sells China distribution business to Shanghai Pharma

...Cardinal Health Inc. (NYSE:CAH) sold its Cardinal Health China distribution business to Shanghai Pharmaceuticals Holding Co...
...to the distributor, and the other by the distributor to the hospital. Cardinal Health Inc. (NYSE:CAH...
BioCentury | Nov 15, 2017
Company News

Cardinal Health sells China distribution business to Shanghai Pharma

...Cardinal Health Inc. (NYSE:CAH) sold its Cardinal Health China distribution business to Shanghai Pharmaceuticals Holding Co...
BioCentury | Oct 13, 2017
Finance

Sprucely debut

...asset, SPR001 , is an orally administered small molecule to treat classic congenital adrenal hyperplasia (CAH...
BioCentury | Jul 21, 2017
Company News

Cardinal seeking buyer for China distribution business

...In a statement , Cardinal Health Inc. (NYSE:CAH) said it has "begun to explore strategic alternatives...
Items per page:
1 - 10 of 101